semaglutide for addiction Semaglutide… alcohol use disorder? 👀, A major 2025 randomized trial showed:, ⬇️ Heavy drinking days, ⬇️ Cravings, ⬇️ Alcohol consumption, This challenges how we think about addiction—and who might Weight loss drug shows promise

Infertility affects roughly 30 to 50% of those diagnosed

Body composition analysis with InBody provides: Accurate BMR measurement for personalised nutrition planning during GLP-1 therapy Visceral fat assessment for metabolic disease risk evaluation at each visit Muscle mass tracking to prevent metabolic slowdown and sarcopenia Phase angle monitoring for cellular health across the treatment course Water distribution analysis for detecting inflammation and fluid imbalance This comprehensive metabolic assessment is alone, and it is now the clinical standard of care in progressive metabolic medicine globally

Hoffmann-La Roche AG (Switzerland), AstraZeneca plc (UK), Amgen Inc

This reversal restores blood-clotting ability but can increase the risk of unwanted clots

Although this class of drugs, called glucagon-like peptide-1 or GLP-1, have been around for more than 17 years, with the first one, Byetta, approved in 2005, it is only recently that the class has made a big name for itself with the introduction of the popular once-weekly diabetic drug, Ozempic , and the equally popular obesity drug, Wegovy (the same drug as Ozempic but with a different dose)

Bacteriostatic Water 10ml The Essential